MOSHE FRANCES: Open Payments
NPI 1417626870 · BAYVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,425 in 70 payments from 14 companies in 2025. Trend: 2023 $2,503 · 2024 $1,551 · 2025 $1,425
Food & beverage: $1,425
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 8 | $311 |
| ABBVIE INC. | 20 | $302 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $264 |
| Vanda Pharmaceuticals Inc. | 7 | $192 |
| Janssen Pharmaceuticals, Inc | 9 | $156 |
| Otsuka America Pharmaceutical, Inc. | 3 | $56 |
| Axsome Therapeutics, Inc. | 2 | $27 |
| Boston Scientific Corporation | 1 | $25 |
| Indivior Inc. | 1 | $18 |
| Braeburn Inc. | 1 | $17 |
Products named: VRAYLAR, CAPLYTA, LYBALVI, FANAPT, INVEGA SUSTENNA, REXULTI, ARISTADA, SPRAVATO.
Industry payments across NJ — which companies pay providers there.
